Profitability
Weight: 20%
F
5
- 5yr Avg ROIC -1.6%
- Operating Margin Trend -6.35 pp/yr
CTKB
Cytek Biosciences, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
D-
28
- 5yr Avg ROE -4.5%
- 5yr Share-Count CAGR -0.8%
Growth Quality
Weight: 15%
A+
96
- 5yr Revenue CAGR 16.8%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 15%
F
10
- 5yr FCF Margin -1.3%
- 5yr FCF/NI Conversion -4.25x
Balance Sheet
Weight: 20%
F
23
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -61.96x
- Altman Z-Score 3.72
Stability
Weight: 15%
B-
65
- EPS Volatility (σ/μ) 0.29
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 4
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 2 added.
- Holders
- 2 +1
- Avg Δ position
- +157.3%
- New buys
- 0
- Full exits
- 0